BSE filing, BSE: 541112. Summary written from the filing by ALFA Finder's alert engine.
Shreeshay Engineers Ltd: key numbers
- Share price
- ₹25.11
- Market cap
- ₹33.15 Cr
- Revenue (annual)
- ₹1.59 Cr
- Net profit (annual)
- ₹0.23 Cr
- P/E (TTM)
- 141.8×Sector 31.7×
- Promoter holding
- 73.10%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shreeshay Engineers Ltd
All →Shreeshay Engineers Management Change
Shreeshay Engineers announced the resignation of CS Jayesh Merchant and the appointment of CS Saksham Jaiswal as the new Company Secretary and Compliance Officer.
Shreeshay Engineers Annual General Meeting
Shreeshay Engineers Limited held its 31st Annual General Meeting on September 28, 2026. The meeting covered routine business, including the adoption of financial statements and director re-appointment.
Shreeshay Engineers Management Change
Shreeshay Engineers Ltd has re-appointed DGMS & CO as its internal auditor for a 24-month term, effective from August 28, 2026.
Shreeshay Engineers Other Announcement
Shreeshay Engineers Limited has appointed M/s. D G M S & Co., Chartered Accountants as Internal Auditor for the financial years 2026-2027 and 2027-2028. This is a routine appointment disclosure.
Shreeshay Engineers Annual General Meeting
Shreeshay Engineers Limited has scheduled its 31st Annual General Meeting (AGM) to be held on Monday, September 28, 2026, via video conferencing.
Shreeshay Engineers Board Meeting Outcome
Shreeshay Engineers Limited announced board approval for the re-appointment of a director and the upcoming 31st Annual General Meeting. Operational routine matters like report approvals were also concluded.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.